⌘K

Login Start Free

Home/Filings/4/0001102624-16-002066

4//SEC Filing

AEOLUS PHARMACEUTICALS, INC. 4

Accession 0001102624-16-002066

CIK 0001261734operating

View on SEC.gov Company Profile

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 4:12 PM ET

Size

7.8 KB

Accession

0001102624-16-002066

Insider Transaction Report

Form 4

Period: 2014-03-04

AEOLUS PHARMACEUTICALS, INC.AOLS

President & CEO

Transactions

Award
Incentive Stock Option (right to buy)
2014-03-04+250,000→ 250,000 total
Exercise: $0.27Exp: 2024-03-04→ Common Stock (250,000 underlying)
Award
Incentive Stock Option (right to buy)
2015-03-04+250,000→ 250,000 total
Exercise: $0.27Exp: 2025-03-04→ Common Stock (250,000 underlying)

Footnotes (1)

[F1]Option will vest in equal monthly installments over a period of twelve months from the date of grant, provided that the reporting person remains an employee of the Company.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

AEOLUS PHARMACEUTICALS, INC.

CIK 0001261734

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001261734

Filing Metadata

Form type: 4
Filed: Feb 2, 7:00 PM ET
Accepted: Feb 3, 4:12 PM ET
Size: 7.8 KB

View on SEC.gov